Mesalamine, a derivative of 5-aminosalicylic acid, is an anti-inflammatory agent. Orally it is used to treat and maintain remission of mild to moderate ulcerative colitis. Rectal administration is used to treat active mild-to-moderate distal ulcerative colitis, proctosigmoiditis, or proctitis.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 1 | 0 | |||||
| loose bowels | 1 | 0 |
Mouse over the table for more information
Currently Taking Mesalamine
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.